How CoronaVirus Accelerated the Rise of Telemedicine (CNBC). Telehealth.
16 minute video on how hospitals and primary care practices are using it and what it could mean for the future of health care.
The Covid-19...
After FDA authorizes at-home saliva test for Covid-19, startups begin selling test kits.
MedCityNews
The FDA gave an emergency use authorization for the first saliva-based Covid-19 test developed by RUCDR Infinite Biologics. Now, startups are once again trying...
Biotech Stock Review Adds One Medical (ONEM) $28.50 to Watchlist.
It Ain't Cheap at $3.5 Billion.It's Near Doubled Since March 20th.But Look at the Growth.Look at the Cash.Don't Look at the Bottom Line.And it's...
Stand Down IX: Is the Country Headed Into a Global Depression? Ray Dalio.
Q: Do you think we're headed into a global depression?
A: Well, yes, but I want to be careful. The word is an evocative word...
https://youtu.be/yrxYhv2O3wU?t=514
TeleHealths’ Screaming Growth in Canada.
"Dialogue says it has also seen a surge of customer interest, with 100 companies subscribing to its annual service in the past two weeks,...
SEC takes enforcement action against 23 companies for claims relating to COVID-19.
Aint Nothing but a Gangter Party.
Like cryptocurrency and cannabis, the coronavirus pandemic may attract fraudsters keen to profit off demand for tests and treatments...
Biotech Stock Review: Mitesco (MITI) $0.03, Report Update
Mitesco to Launch Telehealth Enabled Primary Care Clinic Business with Q4 Rollout Addressing Healthcare Backlog Accentuated by the Second Wave Concerns.
REPORT UPDATE:
Denver, CO, May...
Update: Biotech 5 Pack. 5 Biotech Stocks, we Expected to Double in 2020.
No Doubles Yet, But They're Doing Rather Well, Considering Everything. Our Confidence Remains Unwavered. Best Performer up 63%.
IN ORDER OF SHARE PRICE..LOW TO HIGH
Mitesco...
Citius Pharma (CTXR) Seeks Expeditious Pathway Into the Clinic, for CoronaVirus Related Acute Respiratory...
Sumbmits pre-IND Into Coronavirus Treatment Acceleration Program (CTAP).
Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem...
Latest article
Biotech Stock Review is Back! Timing Feels Perfect. 4 Companies Adding to Watch List....
In 2020, we Released the "Biotech 5 Pack" Which Later Grew to a 6 Pack, with a Byline "6 Stocks We Expect to Double"...
REPORT OpenWorld: The Contrarian’sCase for OPNW
Adding to Watch List. Why VerifyMe's (VRME) $0.90 Reverse Merger Deserves a Second Look. Or First Look for Some.
LIVE QUOTE
RECENT NEWS
VerifyMe Reports Fourth Quarter...
$269 Million in Cash and a $178 Million Market Cap. What are the Odds?...
Wife: "Honey, I'm going to the mall, do we have money in the checking?" CEO "Yes, but don't go crazy, we're down to $269...
